These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7166165)

  • 1. A possible role for human growth hormone (HGH) in the protection from glucose-induced hyperkalemia in normaldosteronemic diabetes.
    Radó JP
    Endokrinologie; 1982 Nov; 80(3):364-6. PubMed ID: 7166165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of glucose-induced hyperkalemia by sodium restriction in normaldosteronemic diabetes: evidence for elevated mineralocorticoid threshold.
    Rado JP
    Biomedicine; 1981 Sep; 35(4):109-11. PubMed ID: 7295860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):239-43. PubMed ID: 7037373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-induced paradoxical increase in HGH with potentiated decrease in serum potassium in chronic renal failure.
    Rado JP
    Horm Metab Res; 1982 Feb; 14(2):105. PubMed ID: 7040190
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of plasma aldosterone by glucose-induced paradoxical hyperkalemia in the presence of suppressed renin-angiotensin system.
    Radó JP
    Endokrinologie; 1978 Apr; 72(1):51-6. PubMed ID: 688983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-induced hyperkalemia in diabetic subjects.
    Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
    Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
    Radó JP
    Exp Clin Endocrinol; 1984 Oct; 84(2):143-7. PubMed ID: 6396097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
    Radó JP; Bános C; Gercsák G; Molnár Z; Pató E; Csabuda M
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):161-4. PubMed ID: 6755590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mineralocorticoids on the paradoxical glucose-induced hyperkalemia in nondiabetic patients with selective hypoaldosteronism.
    Rado JP
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):365-8. PubMed ID: 918352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus and sexual ateliotic dwarfism: a comparative study.
    Merimee TJ; Fineberg SE; McKusick VA; Hall J
    J Clin Invest; 1970 Jun; 49(6):1096-102. PubMed ID: 5422015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
    Lowenthal DT; Gould A; Shirk J; Mazzella J; Affrime MB; Walker F; Onesti G
    Clin Pharmacol Ther; 1980 May; 27(5):671-6. PubMed ID: 6989547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting HGH in diabetes: regulation of ambulatory diabetics.
    Bolinger RE; Kyner JL
    J Kans Med Soc; 1975 Mar; 76(3):64-9, 20. PubMed ID: 1120924
    [No Abstract]   [Full Text] [Related]  

  • 15. Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus.
    Winkler G; Gerö L; Halmos T; Grósz A; Gefferth G; Varga P; Tamás G
    Acta Diabetol Lat; 1987; 24(2):109-17. PubMed ID: 3115018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.
    Goldfarb S; Strunk B; Singer I; Goldberg M
    Am J Med; 1975 Nov; 59(5):744-50. PubMed ID: 1200041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of pronounced hyperkalaemia after arginine infusion in the diabetic subject.
    Massara F; Cagliero E; Bisbocci D; Passarino G; Carta Q; Molinatti GM
    Diabete Metab; 1981 Sep; 7(3):149-53. PubMed ID: 7319114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addison's disease and the regulation of potassium: the role of insulin and aldosterone.
    Harvey TC
    Med Hypotheses; 2007; 69(5):1120-6. PubMed ID: 17459601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.
    Rosenstock J; Loizou SA; Brajkovich IE; Mashiter K; Joplin GF
    Diabetologia; 1982 Mar; 22(3):184-7. PubMed ID: 7042430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.